Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

TLR8 Activators

The Toll-like receptor 8 (TLR8) represents a crucial component of the innate immune system, playing a pivotal role in recognizing viral and bacterial pathogens. Positioned within endosomes, TLR8 primarily senses single-stranded RNA from viruses, such as ssRNA viruses or RNA released during bacterial infections. Upon ligand recognition, TLR8 initiates a signaling cascade that culminates in the activation of various immune responses. TLR8, as a pattern recognition receptor, contributes significantly to the host's ability to discriminate between self and non-self, a fundamental aspect of immune surveillance. Its role in recognizing microbial RNA positions TLR8 as a sentinel at the forefront of immune defenses, capable of discerning the presence of pathogens and triggering subsequent immune responses.Activation of TLR8 involves a series of intricate molecular events that begin with ligand binding and culminate in the modulation of downstream signaling pathways. Ligand engagement induces conformational changes in the receptor, leading to the recruitment of adapter proteins such as MyD88. This interaction initiates a signaling cascade involving IRAK4 and IRAK1, ultimately activating transcription factors like NF-κB and IRF7. The orchestrated activation of these transcription factors instigates the transcription of proinflammatory cytokines and type I interferons, which collectively contribute to the establishment of an antiviral state within the host. The complexity of TLR8 activation is further accentuated by the involvement of accessory molecules, including TLR7, which can form heterodimers with TLR8, adding an additional layer of regulatory sophistication to the immune response. Research endeavors focused on unraveling the intricacies of TLR8 function and activation contribute to a comprehensive understanding of host-pathogen interactions, providing insights into the molecular underpinnings of innate immunity.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

R-848

144875-48-9sc-203231
sc-203231A
sc-203231B
sc-203231C
5 mg
25 mg
100 mg
500 mg
$102.00
$306.00
$510.00
$1559.00
12
(1)

R-848 is a selective TLR8 agonist known for its ability to stimulate innate immune responses through precise receptor interactions. Its unique molecular configuration enables effective binding to TLR8, triggering a cascade of signaling events that enhance cytokine production. The compound's distinctive properties, including its stability and solubility, facilitate efficient cellular uptake and receptor engagement, promoting a swift immune activation process.

Gardiquimod

1020412-43-4sc-221663
sc-221663A
sc-221663B
sc-221663C
sc-221663D
sc-221663E
sc-221663F
25 mg
50 mg
100 mg
250 mg
5 g
10 g
25 g
$157.00
$282.00
$516.00
$1177.00
$20138.00
$32779.00
$70753.00
1
(1)

Gardiquimod is a potent TLR8 agonist that engages the immune system through specific molecular interactions, leading to the activation of various intracellular signaling pathways. Its unique structure allows for selective binding to TLR8, resulting in the modulation of gene expression related to immune responses. The compound exhibits favorable reaction kinetics, promoting rapid cellular responses and enhancing the overall efficacy of immune signaling. Its distinct physicochemical properties support effective receptor activation and downstream effects.

CL097

1026249-18-2sc-507394
5 mg
$135.00
(0)

A synthetic imidazoquinoline compound that activates TLR8, promoting the production of TNF-α and other cytokines.

Imiquimod

99011-02-6sc-200385
sc-200385A
100 mg
500 mg
$67.00
$284.00
6
(1)

A compound that specifically activates TLR8, initiating signal transduction pathways.

Polyuridylic acid potassium salt

27416-86-0sc-215733
sc-215733A
10 mg
25 mg
$189.00
$343.00
2
(1)

A synthetic RNA polymer, known to be a ligand for TLR8, stimulating immune response.